Ignite Creation Date:
2024-05-06 @ 2:45 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04412044
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2020-05-28
Brief Title:
Effect of Anti-interleukin 5 IL5 Therapy on Sputum Cells and Cytokines
Sponsor:
KU Leuven
Organization:
KU Leuven
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
22 asthmatics in which mepolizumab was to be started gave permission for inclusion and were followed up prospectively Clinical and lung functional data sputum analyses and cytokine measurements were analyzed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None